Drug Type siRNA |
Synonyms Csi 102, Csi102 |
Target |
Action inhibitors |
Mechanism HBV core protein inhibitors, IL-6 inhibitors(Interleukin-6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatitis B | Discovery | South Korea | 11 Jun 2024 |





